High immunoproteasome expression is associated with a better prognosis in patients with melanoma [18], and trichostatin A (TSA), an HDAC inhibitor, induces APM-related molecules and increases antigen presentation by MHC class I on the cell surface in melanoma [16]. The gene discussed is HDAC9; the disease is melanoma.